Evaluation and analysis of patients presenting neurodegenerative dementia or parkinsonism with [18F]THK-5351 positron emission tomography
Not Applicable
- Conditions
- mild cognitive impairment(MCI),Alzheimer-type dementia(AD), frontotemporal dementia(FTD), corticobasal degeneration(CBD),progressive supranuclear palsy(PSP),Parkinson's disease with dementia(PDD),dementia with Lewy bodies(DLB),Parkinson's disease(PD),multiple system atrophy(MSA),healthy control(HC)
- Registration Number
- JPRN-UMIN000018496
- Lead Sponsor
- agoya University Department of Neurology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
Persons who several doctors think it is difficult participate the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method About each neurodegenerative disease,We compare [18F]THK-5351 PET imaging with MRI and clnical syndrome.
- Secondary Outcome Measures
Name Time Method